ArticleThe New England journal of medicine2017
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this papertrialcites it